FindTrial
Sign In

Cardiovascular risk assessment in Spondyloarthritis patients

Optimal strategy for Cardiovascular risk assessment in Spondyloarthritis : A comparative analysis between traditional cardiovascular risk score (QRISK3 score) versus traditional risk score supplemented with either Carotid ultrasound or Coronary CT angiography - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/060100
Enrollment
66
Registered
2023-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M45-M49- Spondylopathies

Interventions

Intervention1: NIL: NIL Control Intervention1: Cardiovascular risk assessment by QRISK3 combined with carotid ultrasound: Cardiovascular risk assessment by QRISK3 combined with carotid ultrasound Cont

Sponsors

All India Institute of Medical Sciences (AIIMS), Raipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed case/previously diagnosed case of axial Spondyloarthritis, Ankylosing Spondylitis, or Psoriatic Arthritis

Exclusion criteria

Exclusion criteria: 1. Pregnant women and lactating mother 2. Established cardiovascular diseases 3. History any cardiovascular or cerebrovascular events 4. History of any allergy to contrast agents 5. Presence of chronic kidney disease which is a contraindication for contrast use during CT scan 6. Any other contraindications for radiological investigations like CT or Ultrasound.

Design outcomes

Primary

MeasureTime frame
To compare the accuracy of Cardiovascular (CV) risk estimation in SpA patients by traditional CV risk prediction tool (QRISK3) alone versus traditional CV risk score (QRISK3) combined with either carotid US or coronary CT angiographyTimepoint: End of study period—

Secondary

MeasureTime frame
To compare the cardiovascular (CV) risk estimation by QRISK3 combined with carotid US versus QRISK3 combined with coronary CT angiography in SpA patients for finding out the best tool for CV risk screening.Timepoint: End of study period—

Countries

India

Contacts

Public ContactDr Joydeep Samanta

All India Institute of Medical Sciences (AIIMS), Raipur

samantajoydeep@yahoo.com9836594064

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026